We are live on ! Find out more
PRVL

Prevail Therapeutics Inc. Common Stock
PRVL

Delisted

PRVL was delisted on the 21st of January, 2021.

Back to rankings

46 hedge funds and large institutions have $427M invested in Prevail Therapeutics Inc. Common Stock in 2019 Q4 according to their latest regulatory filings, with 10 funds opening new positions, 15 increasing their positions, 8 reducing their positions, and 6 closing their positions.

New
Increased
Maintained
Reduced
Closed

88% more repeat investments, than reductions

Existing positions increased: 15 | Existing positions reduced: 8

67% more first-time investments, than exits

New positions opened: 10 | Existing positions closed: 6

30% more capital invested

Capital invested by funds: $328M → $427M (+$99.5M)

10% more funds holding

Funds holding: 42 → 46 (+4)

0% more funds holding in top 10

Funds holding in top 10: 2 → 2 (0)

Holders
46
Holders Change
+4
Holders Change %
+9.52%
% of All Funds
0.91%
Holding in Top 10
2
Holding in Top 10 Change
–
Holding in Top 10 Change %
–
% of All Funds
0.04%
New
10
Increased
15
Reduced
8
Closed
6
Calls
–
Puts
–
Net Calls
–
Net Calls Change
–

Top Buyers

Rank Fund Capital Flow
1
Point72 Asset Management
Point72 Asset Management
Connecticut
+$4.67M
2
BlackRock
BlackRock
New York
+$3.41M
3
Citadel Advisors
Citadel Advisors
Florida
+$1.28M
4
UBS Group
UBS Group
Switzerland
+$979K
5
Vanguard Group
Vanguard Group
Pennsylvania
+$911K

Top Sellers

Rank Fund Capital Flow
1
CI
Clal Insurance
Israel
-$3.67M
2
EC
EcoR1 Capital
California
-$1.84M
3
LCM
Laurion Capital Management
New York
-$1.25M
4
SFM
Sphera Funds Management
Israel
-$1.11M
5
Millennium Management
Millennium Management
New York
-$618K
Name Holding Trade Value Shares
Change 		Change in
Stake
JP Morgan Chase
26
JP Morgan Chase
New York
$223K +$149K +11,707 +481%
Morgan Stanley
27
Morgan Stanley
New York
$206K +$110K +8,655 +201%
Wells Fargo
28
Wells Fargo
California
$192K +$97.5K +7,643 +170%
California State Teachers Retirement System (CalSTRS)
29
California State Teachers Retirement System (CalSTRS)
California
$183K – – –
State of Wisconsin Investment Board
30
State of Wisconsin Investment Board
Wisconsin
$179K – – –
New York State Common Retirement Fund
31
New York State Common Retirement Fund
New York
$144K +$106K +8,300 +1,038%
Barclays
32
Barclays
United Kingdom
$119K +$48K +3,761 +99%
AIG
33
American International Group
New York
$74K -$497 -39 -0.8%
TRCT
34
Tower Research Capital (TRC)
New York
$67K +$53.6K +4,206 New
Citigroup
35
Citigroup
New York
$65K +$47.7K +3,736 +965%
FAM
36
Fred Alger Management
New York
$47K +$38.3K +3,000 New
Deutsche Bank
37
Deutsche Bank
Germany
$40K +$6.58K +516 +25%
SO
38
STRS Ohio
Ohio
$30K – – –
Legal & General Group
39
Legal & General Group
United Kingdom
$23K +$2.91K +228 +19%
CSS
40
Cubist Systematic Strategies
Connecticut
$23K +$18.8K +1,476 New
Royal Bank of Canada
41
Royal Bank of Canada
Ontario, Canada
$23K +$19K +1,489 New
Bank of Montreal
42
Bank of Montreal
Ontario, Canada
$15K +$11.9K +936 New
BNP Paribas Financial Markets
43
BNP Paribas Financial Markets
France
$13.7K -$957 -75 -8%
AIP
44
Ameritas Investment Partners
Nebraska
$10K – – –
Daiwa Securities Group
45
Daiwa Securities Group
Japan
$3K +$2.45K +192 New
LCM
46
Laurion Capital Management
New York
– -$1.25M -101,949 Closed
SFM
47
Sphera Funds Management
Israel
– -$1.11M -90,217 Closed
Millennium Management
48
Millennium Management
New York
– -$618K -50,338 Closed
VMI
49
VHCP Management III
New York
– -$54K -4,408 Closed
VMI
50
VHCP Management II
New York
– -$32K -2,604 Closed
1
2
3

PRVL Hedge Fund Activity: Q4 2019 in Review

46 of the 5,075 institutional investors tracked by Wall St. Rank reported a position in Prevail Therapeutics Inc. Common Stock (PRVL) for Q4 2019, worth a combined $427M — up 30% from $328M a quarter earlier.

Buyers outnumbered sellers: 10 funds opened new PRVL positions and 6 closed out — a net gain of 4 holders — while 15 added to existing stakes and 8 trimmed.

The largest buyer was Point72 Asset Management, opening a new position worth an estimated $4.67M. The largest seller was Clal Insurance, cutting an estimated $3.67M.

  • 46 institutional investors held Prevail Therapeutics Inc. Common Stock (PRVL) as of Q4 2019, up from 42 in Q3 2019.
  • Funds reported $427M of Prevail Therapeutics Inc. Common Stock stock for Q4 2019, up 30% quarter-over-quarter.
  • 10 funds opened new Prevail Therapeutics Inc. Common Stock positions in Q4 2019 and 6 closed out, a net change of +4 holders.
  • The largest Prevail Therapeutics Inc. Common Stock buyer in Q4 2019 was Point72 Asset Management, an estimated $4.67M added.
  • The largest Prevail Therapeutics Inc. Common Stock seller in Q4 2019 was Clal Insurance, an estimated $3.67M sold.

Based on aggregated 13F filings for Q4 2019.